CONNECT WITH US
Tech

Tech

Froncort.AI Raises $2.3 Mn From Google.org To Expand AI-Based Disease Surveillance

Inc42 - All News logo

Published on

Add as a preferred source on Google
Froncort.AI Raises $2.3 Mn From Google.org To Expand AI-Based Disease Surveillance

Healthcare AI startup Froncort.AI has secured $2.3 Mn (₹21.5 Cr) in fresh capital from Google’s philanthropic arm, Google.org, to scale its AI-powered disease surveillance and detection platform.

The support also includes $200K in Google Cloud credits and pro bono technical expertise from Google’s AI specialists.

The funding will help Froncort.AI develop mAI-NETRA, a mobile version of its public health platform AI-NETRA, which uses AI, satellite imagery and government health data to identify higher risk areas for catching infectious diseases. It also guides frontline health workers towards targeted screenings.

The startup is among 15 organisations selected globally for Google.org’s Impact Challenge: AI for Government Innovation.

Founded in 2024 by physician-scientist Dr Ujjwal Rao, Froncort.AI aims to improve early disease detection by helping frontline health workers enhance their vigil over disease prone areas.

In a validation study conducted with Maharashtra’s state TB programme,Froncort.AI claims that teams using its AI-NETRA identified a similar number of confirmed pulmonary TB cases while screening two-thirds fewer people than conventional methods.

The cost per confirmed case also declined from around $29K to $10K, while 92% of participating frontline workers reported a lower workload.

The platform combines government health programme data with Google’s Earth AI models and local risk indicators, including settlement density, land use, rainfall and flooding, to identify high-risk geographical clusters.

It then converts these insights into ranked work paths, mapping household clusters and builds routes for health workers to follow during field visits.

AI bids to enhance its platform to extend its capabilities across 6 infectious diseases — TB, Leprosy, Malaria, Dengue, Cholera and Leptospirosis.


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.